According to USP <795>, what is the maximum beyond-use date (BUD) for a nonsterile compounded preparation with a short stability period, stored at room temperature?
14 days
According to USP <795>, nonsterile compounded preparations with a short stability period that are stored at room temperature must have a maximum beyond-use date (BUD) of 14 days. This guideline is crucial for ensuring the safety and efficacy of compounded medications.
This option aligns with the USP <795> guidelines, which specify that nonsterile compounded preparations with a short stability period must be used within 14 days when stored at room temperature. This BUD is designed to minimize the risk of degradation and contamination.
A BUD of 30 days exceeds the recommendations for nonsterile compounded preparations classified as having a short stability period. Such a duration could potentially compromise the safety and effectiveness of the preparation, as it does not align with the established guidelines for these types of compounds.
Selecting 60 days as a BUD is inappropriate for nonsterile compounded preparations with a short stability period. This length of time is significantly longer than what USP <795> permits, which could lead to increased risks of degradation and adverse effects in patients.
A 90-day BUD is not in accordance with USP <795> for nonsterile compounded preparations with short stability. This extended timeframe could result in serious safety concerns, including reduced potency and increased risk of contamination, which the guidelines specifically aim to prevent.
The USP <795> guidelines clearly stipulate that nonsterile compounded preparations with a short stability period must have a maximum beyond-use date of 14 days when stored at room temperature. This regulation is critical for maintaining the integrity and safety of compounded medications, ensuring that patients receive effective and reliable treatments. All other options present durations that exceed the recommended timeframes, potentially compromising patient safety.
Related Questions
View allWhich of the following is a common side effect of metformin?
Which of the following is a Schedule IV controlled substance?
Which of the following is an angiotensin-converting enzyme inhibitor?
Federal law requires which of the following medications to be stored i...
If 30 g of 5% ointment is combined with 10 g of 40% ointment what is t...
Related Quizzes
View allAlabama Property and Casualty License Practice Exam
California Real Estate Practice Final Exam Answers
PSI National Real Estate License Exam Prep
Colorado State Real Estate License Exam
Illinois Real Estate Exam Prep Online
Free Illinois Real Estate Exam Practice Test
Illinois Real Estate Broker Exam Prep
Illinois Real Estate Exam Study Guide PDF
Illinois National Real Estate Exam
Illinois Real Estate State Exam Questions
- ✓ 500+ Practice Questions
- ✓ Detailed Explanations
- ✓ Progress Analytics
- ✓ Exam Simulations